Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs

The Food and Drug Administration’s 2022 inspection of the Sun Pharma factory in India warned of contaminations and deficiencies. But the plant received permission from the FDA to continue shipping more than a dozen generic medications to Americans. Animation by Lisa Larson-Walker/ProPublica. Drone footage for ProPublica.

Rx Roulette

Rx Roulette

Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs

Related reading

The FDA Often Doesn’t Test Generic Drugs for Quality Concerns, So ProPublica Did

FDA declines to issue specific guidance on health programs' foreign drug imports

The “Fauxzempic” Crisis: Counterfeit Innovation Puts Lives—and Markets—at Risk

FDA launches program to encourage American drug manufacturing - UPI.com

FDA floats possible approach to repurpose approved drugs under new uses

China approving innovative drugs at record pace, shifting momentum from West

Related reading

The FDA Often Doesn’t Test Generic Drugs for Quality Concerns, So ProPublica Did

FDA declines to issue specific guidance on health programs' foreign drug imports

The “Fauxzempic” Crisis: Counterfeit Innovation Puts Lives—and Markets—at Risk

FDA launches program to encourage American drug manufacturing - UPI.com

FDA floats possible approach to repurpose approved drugs under new uses

China approving innovative drugs at record pace, shifting momentum from West